期刊文献+

Decreased Number of CD14+TLR4+ Monocytes and Their Impaired Cytokine Responses to Lipopolysaccharide in Patients with Chronic Kidney Disease 被引量:2

Decreased Number of CD14+TLR4+ Monocytes and Their Impaired Cytokine Responses to Lipopolysaccharide in Patients with Chronic Kidney Disease
下载PDF
导出
摘要 This study aimed to examine the number of circulating Toll-like receptor 4(TLR4) + CD14+ monocytes in patients with different stages of chronic kidney disease(CKD), their responses to lipopolysaccharide(LPS), and to explore the potential association of the number of TLR4+CD14+ monocytes with clinical laboratory measures. The numbers of TLR4+CD14+, LPS-stimulated TNF-?+CD14+ and interleukin(IL)-6+CD14+ monocytes were determined by flow cytometry in 9 patients with stage 3 CKD, 11 with stage 4 CKD, 16 with stage 5 CKD, and 19 healthy controls(HCs). Their laboratory tests were performed by routine methods and the potential association among these measures was analyzed by Pearson's correlation analysis. The numbers of CD14+, CD14+TLR4+, LPSstimulated TNF-?+CD14+ and IL-6+CD14+ monocytes in patients with CKD were significantly less than those of HCs(all P〈0.05), and were negatively associated with patient disease severity. The number of CD14+TLR4+ monocytes was positively correlated with estimated glomerular filtration rate(e GFR, P〈0.001) and the levels of hematocrit(P〈0.01), but negatively correlated with the levels of blood urine nitrogen, serum creatinine, and C-reactive protein(P〈0.001 for all), in the CKD patients. Our data indicate that significant reduction in the number of TLR4+ monocytes and their impaired responses to LPS may be associated with the progression of CKD in Chinese patients. This study aimed to examine the number of circulating Toll-like receptor 4(TLR4) + CD14+ monocytes in patients with different stages of chronic kidney disease(CKD), their responses to lipopolysaccharide(LPS), and to explore the potential association of the number of TLR4+CD14+ monocytes with clinical laboratory measures. The numbers of TLR4+CD14+, LPS-stimulated TNF-?+CD14+ and interleukin(IL)-6+CD14+ monocytes were determined by flow cytometry in 9 patients with stage 3 CKD, 11 with stage 4 CKD, 16 with stage 5 CKD, and 19 healthy controls(HCs). Their laboratory tests were performed by routine methods and the potential association among these measures was analyzed by Pearson's correlation analysis. The numbers of CD14+, CD14+TLR4+, LPSstimulated TNF-?+CD14+ and IL-6+CD14+ monocytes in patients with CKD were significantly less than those of HCs(all P〈0.05), and were negatively associated with patient disease severity. The number of CD14+TLR4+ monocytes was positively correlated with estimated glomerular filtration rate(e GFR, P〈0.001) and the levels of hematocrit(P〈0.01), but negatively correlated with the levels of blood urine nitrogen, serum creatinine, and C-reactive protein(P〈0.001 for all), in the CKD patients. Our data indicate that significant reduction in the number of TLR4+ monocytes and their impaired responses to LPS may be associated with the progression of CKD in Chinese patients.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2015年第2期206-211,共6页 华中科技大学学报(医学英德文版)
关键词 Kidney creatinine interleukin Cytokine glomerular cytometry impaired severity filtration urine Kidney creatinine interleukin Cytokine glomerular cytometry impaired severity filtration urine
  • 相关文献

参考文献23

  • 1Collins AJ, Yee J. Infectious complications in patients with chronic kidney disease. Adv Chronic Kidney Dis, 2006,13(3):197-198.
  • 2Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis, 2006,13(3):199- 204.
  • 3Shinzato T, Nakai S, Akiba T, et al. Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int, 1999,55(2):700-712.
  • 4Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol, 2005,3(1):36-46.
  • 5Palsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharidc receptor, Toll-like receptor-4. Immunology, 2004,113 (2): 153-162.
  • 6Agnese DM, Calvano JE, Hahm S J, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis, 2002,186(10): 1522-1525.
  • 7Kumpf O, Giamarellos-Bourboulis EJ, Koch A, et al. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit Care, 2010,14(3):R103.
  • 8Ando M, Shibuya A, Tsuchiya K, et al. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int, 2006,70(2):358-362.
  • 9Gollapudi P, Yoon JW, Gollapudi S, et al. Leukocyte toll- like receptor expression in end-stage kidney disease. Am J Nephrol, 2010,31(3):247-254.
  • 10National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002,39(2 Suppl 1):S1- $266.

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部